Mohammad Bilal1,2, Osama Alhajjar3, Matthew Madisetty3, Vamsi Kantamaneni3, Shailendra Singh4, Michael Babich4, Anastasios Kapetanos3. 1. Department of Internal Medicine, Allegheny General Hospital, 320 East North Ave, Pittsburgh, PA, 15212, USA. mobilal@utmb.edu. 2. Division of Gastroenterology and Hepatology, The University of Texas Medical Branch, 301 University Blvd., Galveston, TX, 77555, USA. mobilal@utmb.edu. 3. Department of Internal Medicine, Allegheny General Hospital, 320 East North Ave, Pittsburgh, PA, 15212, USA. 4. Division of Gastroenterology, Hepatology and Nutrition, Allegheny General Hospital, 320 East North Ave, Pittsburgh, PA, 15212, USA.
Abstract
BACKGROUND: While the available literature recommends placement of two large-bore intravenous (2LBIV) lines in every patient presenting with acute GIB, the adherence and impact of this recommendation have never before been reported. AIMS: We designed a quality improvement project to assess whether the patients presenting to our institution with acute GIB have appropriate intravenous (IV) access or not. METHODS: We conducted a prospective, observational study, of all patients presenting to our emergency department with overt GIB over a 2-month period. Data analysis was performed, and based on the results, an intervention plan was developed and executed. Post-intervention data collection was done over a 3-month period. Our interventions included physician and nursing education, placing posters in the emergency department, and creation of an order set in the electronic medical record system. RESULTS: A total of 46 patients were in the pre-intervention group, and 71 patients were in the post-intervention group. The presence of 2LBIV lines in the pre-intervention group was only 19.5%, which improved to 36.6% in the post-intervention group (p = 0.049). Factors associated with placement of 2LBIV lines were being in the post-intervention group and admission to the intensive care unit. CONCLUSION: The relatively simple and cost-effective intervention of placing 2LBIV lines is not often executed. We suggest that specific mention of 2LBIV placement in guidelines from national gastroenterology societies might improve compliance in this aspect.
BACKGROUND: While the available literature recommends placement of two large-bore intravenous (2LBIV) lines in every patient presenting with acute GIB, the adherence and impact of this recommendation have never before been reported. AIMS: We designed a quality improvement project to assess whether the patients presenting to our institution with acute GIB have appropriate intravenous (IV) access or not. METHODS: We conducted a prospective, observational study, of all patients presenting to our emergency department with overt GIB over a 2-month period. Data analysis was performed, and based on the results, an intervention plan was developed and executed. Post-intervention data collection was done over a 3-month period. Our interventions included physician and nursing education, placing posters in the emergency department, and creation of an order set in the electronic medical record system. RESULTS: A total of 46 patients were in the pre-intervention group, and 71 patients were in the post-intervention group. The presence of 2LBIV lines in the pre-intervention group was only 19.5%, which improved to 36.6% in the post-intervention group (p = 0.049). Factors associated with placement of 2LBIV lines were being in the post-intervention group and admission to the intensive care unit. CONCLUSION: The relatively simple and cost-effective intervention of placing 2LBIV lines is not often executed. We suggest that specific mention of 2LBIV placement in guidelines from national gastroenterology societies might improve compliance in this aspect.
Authors: Douglas G Adler; Jonathan A Leighton; Raquel E Davila; William K Hirota; Brian C Jacobson; Waqar A Qureshi; Waqar A Quereshi; Elizabeth Rajan; Marc J Zuckerman; Robert D Fanelli; R David Hambrick; Todd Baron; Douglas O Faigel Journal: Gastrointest Endosc Date: 2004-10 Impact factor: 9.427
Authors: Waqar Qureshi; Douglas G Adler; Raquel Davila; James Egan; William Hirota; Jonathan Leighton; Elizabeth Rajan; Marc J Zuckerman; Robert Fanelli; Jo Wheeler-Harbaugh; Todd H Baron; Douglas O Faigel Journal: Gastrointest Endosc Date: 2005-11 Impact factor: 9.427